Recruiting

Observational Study

Sponsor:

Towson University

Code:

NCT04720118

Conditions

Parkinson Disease

Covid19

Satisfaction, Patient

Quality of Life

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Accepted

Interventions

No Intervention

Study Details

Brief summary:

The purpose of this research study is to examine the relationship between personal characteristics and satisfaction with care in those diagnosed with Parkinson's disease during the COVID-19 pandemic. Participants will take 4 different surveys regarding their satisfaction with care throughout the duration of the COVID-19 pandemic. The surveys in total should not take more than 30 minutes to complete

Conditions

Parkinson Disease

Covid19

Satisfaction, Patient

Quality of Life

Study ID

NCT04720118

Start date

Mar 1, 2021

Status verified date

Mar, 2021

Completion date

May, 2021

Anticipated

Primary completion date

Apr, 2021

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Accepted

Inclusion Criteria:

  • 18 years or older
  • Diagnosed with Parkinson's Disease
  • Must be able to complete the surveys without any help

Exclusion Criteria:

  • Under the age of 18
  • Not diagnosed with Parkinson's Disease
  • Unable to complete the surveys without help

Study Design

Enrollment

150 participants

Anticipated

Interventions and Outcome Measures

Interventions

No Intervention

There is no intervention for this study.

Primary outcome measure

  • Measure of the relationship between Locus of Control and Quality of Life [ Time Frame: 1 year ]
  • Measure of secondary control and satisfaction with care [ Time Frame: 1 year ]

Central Contacts and Locations

Central contacts

Locations

Towson University

Recruiting

Towson, Maryland, United States, 21204

Contacts

More Information

Sponsor

Towson University

Last update posted

Apr 1, 2021

Last verified

Mar, 2021

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Towson University on 2021-04-01.